Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
THERMA WAVE INC (TWAV)
|
Add to portfolio |
|
|
|
| Price: |
$1.63
| | Metrics |
| OS: |
37.1
|
M
| |
27
|
% ROE
|
| Market cap: |
$60.5
|
M
| |
-101
|
% ROIC
|
|
Net cash:
|
$14.7
|
M
| |
$0.39
|
per share
|
|
EV:
|
$45.8
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($9.0)
|
M
| |
|
|
|
EBIT
|
($10.0)
|
M
| |
|
|
| EPS |
$153.13
| |
0.0
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Mar-31-06 | Mar-31-05 | Mar-31-04 | Mar-31-03 | Mar-31-02 | Mar-31-01 | Mar-31-00 |
| Revenues | 66.3 | 81.3 | 65.3 | 49.2 | 81.9 | 198.2 | 115.7 |
| Revenue growth | -18.4% | 24.4% | 32.7% | -39.9% | -58.7% | 71.3% | |
| Cost of goods sold | 42.8 | 44.6 | 38.5 | 55.1 | 65.4 | 101.4 | 60.3 |
| Gross profit | 23.4 | 36.6 | 26.8 | -5.8 | 16.5 | 96.8 | 55.4 |
| Gross margin | 35.4% | 45.1% | 41.0% | -11.9% | 20.2% | 48.8% | 47.9% |
| Selling, general and administrative | 40.9 | 43.2 | 44.8 | 128.7 | 69.2 | 28.2 | 20.8 |
| Research and development | | | | | 29.1 | 33.9 | 21.7 |
| EBITA | -25.5 | -5.8 | -15.4 | -65.6 | -35.6 | 33.4 | 14.5 |
| EBITA margin | -38.5% | -7.1% | -23.6% | -133.3% | -43.5% | 16.9% | 12.5% |
| Amortization of intangibles | 0.6 | 0.8 | 2.5 | 1.5 | 0.7 | 0.5 | 1.7 |
| EBIT | -26.2 | -6.5 | -17.9 | -67.1 | -36.3 | 33.0 | 12.8 |
| EBIT margin | -39.5% | -8.0% | -27.5% | -136.4% | -44.3% | 16.6% | 11.0% |
| Pre-tax income | -8.9 | -6.4 | -18.1 | -133.6 | -50.3 | 34.2 | -2.2 |
| Income taxes | -0.1 | 0.5 | 0.0 | 0.0 | -1.1 | 2.0 | 0.0 |
| Tax rate | 1.6% | | 0.0% | 0.0% | 2.2% | 5.9% | 0.0% |
| Net income | 0.0 | 0.0 | 0.0 | -133.6 | -49.2 | 25.8 | -21.5 |
| Net margin | 0.0% | 0.0% | 0.0% | -271.4% | -60.0% | 13.0% | -18.6% |
| |
| Diluted EPS | ($0.25) | ($0.19) | ($0.56) | ($4.69) | ($1.98) | $1.02 | ($1.72) |
| Shares outstanding (diluted) | 0.0 | 0.0 | 0.0 | 28.5 | 24.9 | 25.3 | 12.5 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|